<qa>  What is the STUDY OF SUBCUTANEOUS TOCILIZUMABA STUDY OF SUBCUTANEOUS TOCILIZUMAB AS MONOTHERAPY ANDOR IN COMBINATION WITH NON-BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS DMARDS IN PARTICIPANTS WITH RHEUMATOID ARTHRITIS: 